Publication date: Jul 26, 2024
The COVID-19 pandemic has highlighted the importance of evidence-informed priority setting and situational analysis in pandemic preparedness and response. Health Technology Assessment (HTA) has been identified as an essential tool for evidence-informed decision-making in healthcare. However, the potential role of HTA in pandemic preparedness and response in Africa has yet to be explored. The objective of this scoping review is to ascertain the current understanding of the possible role of HTA in Africa to support future pandemic preparedness and response. We will conduct a scoping review of literature published between 2010 and 2024. Electronic databases like Embase, PubMed, Scopus, Web of Science, and Google Scholar will be utilized to perform the search. We will also search grey literature sources such as websites of relevant organizations and government agencies. The search will only include studies that were conducted in the English language. Two reviewers will evaluate the titles and abstracts of the publications independently to determine their eligibility using Covidence. Full-text articles will be reviewed for eligibility and data extraction. The data will be extracted using a standardized form. The extracted data will include information on the study design, objectives, methods, findings, and conclusions. The thematic analysis approach will guide the data analysis. Themes and sub-themes will be identified and reported. The review will be reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR) guidelines. This scoping review will identify the existing knowledge on the potential role of HTA in Africa to support future pandemic preparedness and response. The findings will aid in identifying deficiencies in knowledge and provide valuable insights for future study. Additionally, they will inform policy-makers and other stakeholders about the potential contribution of the Health Technology Assessment (HTA) in enhancing Africa’s readiness and response to pandemics.
Open Access PDF
| Concepts | Keywords |
|---|---|
| Africa | Africa |
| Databases | Assessment |
| Evidence | |
| Healthcare | Future |
| Valuable | Hta |
| Informed | |
| Pandemic | |
| Potential | |
| Preparedness | |
| Priority | |
| Response | |
| Scoping | |
| Search | |
| Setting | |
| Situational |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | VO | protocol |
| disease | MESH | COVID-19 pandemic |
| disease | VO | study design |
| drug | DRUGBANK | Coenzyme M |
| disease | MESH | infections |
| disease | MESH | Polio |
| disease | MESH | monkeypox |
| disease | MESH | emergencies |
| disease | MESH | Middle East Respiratory Syndrome |
| disease | MESH | death |
| drug | DRUGBANK | Aspartame |
| disease | VO | vaccination |
| disease | IDO | contact tracing |
| disease | IDO | country |
| disease | VO | efficient |
| disease | VO | population |
| disease | IDO | production |
| disease | VO | vaccine |
| disease | IDO | intervention |
| disease | VO | effectiveness |
| disease | VO | Equity |
| disease | MESH | endemic diseases |
| disease | IDO | process |
| disease | MESH | infectious diseases |
| disease | VO | document |
| drug | DRUGBANK | Trestolone |
| disease | VO | manufacturing |
| disease | IDO | infection |
| disease | VO | publication |
| disease | VO | report |
| disease | VO | Gap |
| disease | MESH | influenza |
| disease | VO | organization |
| disease | MESH | ebola hemorrhagic fever |
| disease | VO | effective |
| disease | VO | Apa |
| disease | VO | volume |
| drug | DRUGBANK | Acetylcholine |
| drug | DRUGBANK | Methyl isocyanate |
| drug | DRUGBANK | Spinosad |